Internal Medicine, Hematology & Oncology · Baltimore, MD
NPI
1467733113
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
401 North Broadway, Weinberg Bdg.
Baltimore, MD, 21231
Phone (410) 955-3974
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
158 services
Medicare patients, 2024
78
Average age 74
Drug cost, 2024
$1.0M
145 prescriptions
Company payments, 2025
$42K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patrick Forde was code 99215 (office e&m - established), 111 times for 59 patients. In total Patrick Forde billed 158 services in 8 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 111 | 59 | $110.51 | $12K |
| 99215 Office E&M - Established | Office | 18 | 16 | $136.35 | $2,454 |
| 99205 Office E&M - New | Facility | 11 | 11 | $147.29 | $1,620 |
By year: 2022 $35K for 306 services; 2023 $36K for 319 services; 2024 $17K for 158 services.
Medicare prescription drug claims, 2024
In 2024, the drug Patrick Forde prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 36 prescriptions and refills. In total Patrick Forde wrote 145 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 36 | 36 | Under 11 | $585K |
| Prochlorperazine Maleate Generic | 16 | 16 | Under 11 | $180 |
| Xalkori Crizotinib | 14 | 14 | Under 11 | $288K |
| Tamsulosin Hcl Generic | 12 | 12 | Under 11 | $34.44 |
Brand drugs: 65 claims; generic drugs: 80 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patrick Forde $42K ($42K in general payments such as food, travel and fees) from 11 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $13K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $13K |
| AstraZeneca UK Limited AZN | 4 | $6,989 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $6,194 |
| Abbvie Inc. ABBV | 4 | $4,516 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 6 | $4,430 |
| Novocure Inc. NVCR | 1 | $2,800 |
| Amgen Inc. AMGN | 1 | $2,058 |
| Lantheus Medical Imaging, Inc. LNTH | 1 | $788 |
| Daiichi Sankyo Inc. 4568.T | 1 | $781 |
| Dr.Reddy's Laboratories,Inc. RDY | 1 | $310 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.